Page last updated: 2024-09-05
bw 501c and tertatolol
bw 501c has been researched along with tertatolol in 1 studies
Compound Research Comparison
| Studies (bw 501c) | Trials (bw 501c) | Recent Studies (post-2010) (bw 501c) | Studies (tertatolol) | Trials (tertatolol) | Recent Studies (post-2010) (tertatolol) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 137 | 29 | 2 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bouysset, F; Laubie, M; Schmitt, H; Vayssettes-Courchay, C; Verbeuren, TJ | 1 |
Other Studies
1 other study(ies) available for bw 501c and tertatolol
| Article | Year |
|---|---|
The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.
Topics: Amidines; Anesthesia; Animals; Blood Pressure; Carotid Body; Denervation; Heart Rate; Hemodynamics; Hexamethonium Compounds; In Vitro Techniques; Indoles; Lung; Male; Myocardium; Piperidines; Prazosin; Pressoreceptors; Propanolamines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Renin-Angiotensin System; Ritanserin; Sympathetic Nervous System; Thiophenes; Tropisetron; Vagotomy | 1990 |